The Beauty Health Company
- 🦄Became a unicorn2021
- 📈Peak valuation$4 Billion ’21
- 💔Became a Unitard2022
- 💸Last valuation estimate~$160M
The rise & fall
5 moments · 2021–2023The key moments.
How it happened
The Beauty Health Company makes Hydrafacial, the popular facial-treatment system sold to spas and dermatology clinics, along with other aesthetic devices. It went public in May 2021 via a SPAC merger with Brent Saunders' Vesper Healthcare Acquisition Corp, and its stock soared to lift its market value to roughly $4B by late 2021.
A device-sales slump, recalls and a cooling aesthetics market then crushed it; the stock fell about 96%, leaving Beauty Health worth around $150M — a fraction of its peak.
Glassdoor reviews described high turnover and a management culture many reviewers called toxic, with ratings sliding from 2022 onward.
Employee accounts paraphrase anonymous, unverified reviews posted publicly on Glassdoor ↗. See our methodology.
Source: stockanalysis / PitchBook / SEC (SPAC merger with Vesper Healthcare Acquisition Corp May 2021; ATH ~$28 late 2021 (~$4B); ~$147M market cap by 2026, -96%; device sales slumped)
Who ran it
Current roles as self-reported on LinkedIn, retrieved 2026-08-19. See our methodology.
Disclosed investors (5)
Historical funding participation; lists may be incomplete and do not establish current ownership or investor losses.
* Lead in a funding round · Crunchbase ↗ · 2026-10-13 · Methodology · Leaderboard
